Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01535495 · ClinicalTrials.gov registry record · Phase 1
Propranolol for Diabetic Retinopathy
A Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT01535495 is a Phase 1 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 9 participants.
The verdict
NCT01535495, a Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study is investigating if the oral beta antagonist propranolol can induce regression of retinal neovascularization associated with proliferative diabetic retinopathy.
Interventions
- DRUG Propranolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01535495
The ClinicalTrials.gov registry entry for NCT01535495 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Propranolol is the first listed.
NCT01535495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01535495 about?
NCT01535495 is a clinical study titled "Propranolol for Diabetic Retinopathy". This study is investigating if the oral beta antagonist propranolol can induce regression of retinal neovascularization associated with proliferative diabetic retinopathy.
What is the current status of trial NCT01535495?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2012-02. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01535495?
The interventions under investigation include: Propranolol (DRUG).
Who is sponsoring clinical trial NCT01535495?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.